Morning all!

Brady ( Brady (LON:BRY) ) – 56.5p – £47m – PER 48

Results For The 12 Months To End December 2018 – Revenue up 4%, Gross Profit up 15%, Net Cash at £4.6m (£4.1m last time).

Will take this off my Avoid list now and move it to Neutral.

IEnergizer ( iEnergizer (LON:IBPO) ) – 122p – £233m – PER 9.4

Trading Update – FY Revenue expected to be ahead with Operating Profit expected to be significantly ahead of market expectations – Due to focus on recurring high margin revenue streams.

Still lots to like here but still really hard to buy with a Spread >10% and Free Float <20%. I try and sneak an order in here (at a decent spread point) now and again but never get filled.

Microgen ( Microgen (LON:MCGN) ) – 442p – £270m – PER 21.5

Results For The 12 Months To End December 2018 – Revenue up 12%, Adjusted Operating Profit up 9%, Adjusted Basic EPS up 8%, the FY Dividend is up 6%.

I still see this as fairly priced (at best) here.

Medica Group ( Medica (LON:MGP) ) – 125p – £139m – PER 15.2

Results For The 12 Months To End December 2018 – Revenue up 15.6%, Gross Profit Margin up slightly to 49%, Adjusted Operating Profit up 12.8%, Adjusted EPS up 12%, FY Dividend of 2.25p (1.65p last time), Net Debt down from £5m to 0. Expects double digit Revenue growth this year again. CEO to step down at some point in 2019.

As an ex-holder I am not yet tempted back in here.

Quixant ( Quixant (LON:QXT) ) – 332p – £220m – PER 16

Results For The 12 Months To End December 2018 – Revenue up 5%, Adjusted PBT up 5%, Adjusted Diluted EPS up 14%, Net Cash up 40% (to $11.3m), the FY Dividend is up 19%.

As an ex-holder, I still quite like this but reckon it's probably about fairly priced about here.

Spectra Systems ( Spectra Systems (LON:SPSY) )…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here